115 related articles for article (PubMed ID: 36588334)
1. Revisiting the South Indian Traditional Plants against Several Targets of SARS-CoV-2 - An
Jupudi S; Rajala S; Gaddam NR; Swaminathan G; Peesa JP; Rajagopal K; Azam MA
Curr Comput Aided Drug Des; 2023; 19(3):202-233. PubMed ID: 36588334
[TBL] [Abstract][Full Text] [Related]
2. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An
Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR
Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906
[TBL] [Abstract][Full Text] [Related]
3. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
[TBL] [Abstract][Full Text] [Related]
4. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
5. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach.
Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S
Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164
[TBL] [Abstract][Full Text] [Related]
6. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
7. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach.
Fadaka AO; Aruleba RT; Sibuyi NRS; Klein A; Madiehe AM; Meyer M
J Biomol Struct Dyn; 2022 May; 40(8):3416-3427. PubMed ID: 33200673
[TBL] [Abstract][Full Text] [Related]
9. In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2.
Hashem HE; Ahmad S; Kumer A; Bakri YE
Sci Rep; 2024 Jan; 14(1):1152. PubMed ID: 38212472
[TBL] [Abstract][Full Text] [Related]
10. Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses.
Elkarhat Z; Charoute H; Elkhattabi L; Barakat A; Rouba H
J Biomol Struct Dyn; 2022 Jan; 40(1):361-374. PubMed ID: 32873176
[TBL] [Abstract][Full Text] [Related]
11. Multi-target potential of Indian phytochemicals against SARS-CoV-2: A docking, molecular dynamics and MM-GBSA approach extended to Omicron B.1.1.529.
Roshni J; Vaishali R; Ganesh KS; Dharani N; Alzahrani KJ; Banjer HJ; Alghamdi AH; Theyab A; Ahmed SS; Patil S
J Infect Public Health; 2022 Jun; 15(6):662-669. PubMed ID: 35617830
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
Purohit P; Dash JJ; Muya JT; Meher BR
J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
[TBL] [Abstract][Full Text] [Related]
13.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
14. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[
